MI2AMI-CS: A meta-analysis comparing Impella and IABP outcomes in Acute Myocardial Infarction-related Cardiogenic Shock

Cardiogenic Shock (CS) complicating acute myocardial infarction (AMI) poses a significant mortality risk, suggesting the opportunity to implement effective mechanical circulatory support strategies. The comparative efficacy of Intra-Aortic Balloon Pump (IABP) and Impella in managing CS-AMI remains a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cardiology 2024-11, Vol.414, p.132411, Article 132411
Hauptverfasser: De Ferrari, Tommaso, Pistelli, Lorenzo, Franzino, Marco, Molinero, Agustin Ezequiel, De Santis, Giulia Azzurra, Di Carlo, Alessandro, Vetta, Giampaolo, Parlavecchio, Antonio, Fimiani, Luigi, Picci, Andrea, Certo, Giuseppe, Parisi, Francesca, Venuti, Giuseppe
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 132411
container_title International journal of cardiology
container_volume 414
creator De Ferrari, Tommaso
Pistelli, Lorenzo
Franzino, Marco
Molinero, Agustin Ezequiel
De Santis, Giulia Azzurra
Di Carlo, Alessandro
Vetta, Giampaolo
Parlavecchio, Antonio
Fimiani, Luigi
Picci, Andrea
Certo, Giuseppe
Parisi, Francesca
Venuti, Giuseppe
description Cardiogenic Shock (CS) complicating acute myocardial infarction (AMI) poses a significant mortality risk, suggesting the opportunity to implement effective mechanical circulatory support strategies. The comparative efficacy of Intra-Aortic Balloon Pump (IABP) and Impella in managing CS-AMI remains a subject of investigation. This meta-analysis aims to evaluate the comparative effectiveness of Impella and IABP in managing CS-AMI, exploring mortality and adverse events. A systematic search of major databases from inception to November 2023 identified eight studies, comprising 10,628 patients, comparing Impella and IABP in CS-AMI. Retrospective studies (preferably Propensity-matched) and Randomized Clinical Trials (RCTs) were included. Impella use exhibited significantly higher mortality (57% vs. 46%; OR: 1.44, 95% CI: 1.29–1.60; p 
doi_str_mv 10.1016/j.ijcard.2024.132411
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3087562640</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0167527324010337</els_id><sourcerecordid>3087562640</sourcerecordid><originalsourceid>FETCH-LOGICAL-c287t-e0378cbb6ab0924f1a2e879a9e3ddb52e5f57d8b3bc3720f7d68cf0893a634943</originalsourceid><addsrcrecordid>eNp9kMuO1DAQRS0EYpqBP0DISzZp_Epss0DKtHhEmhZIA2vLsSuDmyRu7ATUf0-iDCxZ1aLOrcdB6CUle0po9ea0Dydnk98zwsSeciYofYR2VElRUFmKx2i3YLIomeRX6FnOJ0KI0Fo9RVdcEy0qXu7Q72PD6mNTHO7e4hoPMNnCjra_5JCxi8PZpjDe42Y4Q99bbEePm_rmC47ztHQh4zDi2s0T4OMlrtcE2-Nm7GxyU4hjkaC3E3h8WFvxHsbg8N336H48R08622d48VCv0bcP778ePhW3nz82h_q2cEzJqQDCpXJtW9mWaCY6ahkoqa0G7n1bMii7UnrV8tZxyUgnfaVcR5TmtuJCC36NXm9zzyn-nCFPZgjZrc-MEOdsOFGyrFglyIKKDXUp5pygM-cUBpsuhhKzKjcnsyk3q3KzKV9irx42zO0A_l_or-MFeLcBsPz5K0Ay2QUYHfiQwE3Gx_D_DX8AK-iTXQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3087562640</pqid></control><display><type>article</type><title>MI2AMI-CS: A meta-analysis comparing Impella and IABP outcomes in Acute Myocardial Infarction-related Cardiogenic Shock</title><source>Access via ScienceDirect (Elsevier)</source><creator>De Ferrari, Tommaso ; Pistelli, Lorenzo ; Franzino, Marco ; Molinero, Agustin Ezequiel ; De Santis, Giulia Azzurra ; Di Carlo, Alessandro ; Vetta, Giampaolo ; Parlavecchio, Antonio ; Fimiani, Luigi ; Picci, Andrea ; Certo, Giuseppe ; Parisi, Francesca ; Venuti, Giuseppe</creator><creatorcontrib>De Ferrari, Tommaso ; Pistelli, Lorenzo ; Franzino, Marco ; Molinero, Agustin Ezequiel ; De Santis, Giulia Azzurra ; Di Carlo, Alessandro ; Vetta, Giampaolo ; Parlavecchio, Antonio ; Fimiani, Luigi ; Picci, Andrea ; Certo, Giuseppe ; Parisi, Francesca ; Venuti, Giuseppe</creatorcontrib><description>Cardiogenic Shock (CS) complicating acute myocardial infarction (AMI) poses a significant mortality risk, suggesting the opportunity to implement effective mechanical circulatory support strategies. The comparative efficacy of Intra-Aortic Balloon Pump (IABP) and Impella in managing CS-AMI remains a subject of investigation. This meta-analysis aims to evaluate the comparative effectiveness of Impella and IABP in managing CS-AMI, exploring mortality and adverse events. A systematic search of major databases from inception to November 2023 identified eight studies, comprising 10,628 patients, comparing Impella and IABP in CS-AMI. Retrospective studies (preferably Propensity-matched) and Randomized Clinical Trials (RCTs) were included. Impella use exhibited significantly higher mortality (57% vs. 46%; OR: 1.44, 95% CI: 1.29–1.60; p &lt; 0.001) and major bleeding (30% vs 15%; OR: 2.93, 95% CI: 1.67–5.13; p &lt; 0.001). In unselected CS-AMI patients, Impella usage is associated with significantly higher mortality and major bleeding. [Display omitted] •In unselected patients with AMI complicated by CS, use of Impella is burdened by higher mortality compared to IABP.•Higher mortality with Impella is likely attributable to increased rate of major bleeding and renal complications.•Since not all patients benefit from Impella, its usage should be tailored to the patient clinical presentation.</description><identifier>ISSN: 0167-5273</identifier><identifier>ISSN: 1874-1754</identifier><identifier>EISSN: 1874-1754</identifier><identifier>DOI: 10.1016/j.ijcard.2024.132411</identifier><identifier>PMID: 39094635</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Acute myocardial infarction ; Adverse events ; Cardiogenic shock ; Impella ; Intra-aortic balloon pump ; Major bleeding ; Mortality ; Percutaneous mechanical circulatory support</subject><ispartof>International journal of cardiology, 2024-11, Vol.414, p.132411, Article 132411</ispartof><rights>2024 The Author(s)</rights><rights>Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c287t-e0378cbb6ab0924f1a2e879a9e3ddb52e5f57d8b3bc3720f7d68cf0893a634943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijcard.2024.132411$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39094635$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>De Ferrari, Tommaso</creatorcontrib><creatorcontrib>Pistelli, Lorenzo</creatorcontrib><creatorcontrib>Franzino, Marco</creatorcontrib><creatorcontrib>Molinero, Agustin Ezequiel</creatorcontrib><creatorcontrib>De Santis, Giulia Azzurra</creatorcontrib><creatorcontrib>Di Carlo, Alessandro</creatorcontrib><creatorcontrib>Vetta, Giampaolo</creatorcontrib><creatorcontrib>Parlavecchio, Antonio</creatorcontrib><creatorcontrib>Fimiani, Luigi</creatorcontrib><creatorcontrib>Picci, Andrea</creatorcontrib><creatorcontrib>Certo, Giuseppe</creatorcontrib><creatorcontrib>Parisi, Francesca</creatorcontrib><creatorcontrib>Venuti, Giuseppe</creatorcontrib><title>MI2AMI-CS: A meta-analysis comparing Impella and IABP outcomes in Acute Myocardial Infarction-related Cardiogenic Shock</title><title>International journal of cardiology</title><addtitle>Int J Cardiol</addtitle><description>Cardiogenic Shock (CS) complicating acute myocardial infarction (AMI) poses a significant mortality risk, suggesting the opportunity to implement effective mechanical circulatory support strategies. The comparative efficacy of Intra-Aortic Balloon Pump (IABP) and Impella in managing CS-AMI remains a subject of investigation. This meta-analysis aims to evaluate the comparative effectiveness of Impella and IABP in managing CS-AMI, exploring mortality and adverse events. A systematic search of major databases from inception to November 2023 identified eight studies, comprising 10,628 patients, comparing Impella and IABP in CS-AMI. Retrospective studies (preferably Propensity-matched) and Randomized Clinical Trials (RCTs) were included. Impella use exhibited significantly higher mortality (57% vs. 46%; OR: 1.44, 95% CI: 1.29–1.60; p &lt; 0.001) and major bleeding (30% vs 15%; OR: 2.93, 95% CI: 1.67–5.13; p &lt; 0.001). In unselected CS-AMI patients, Impella usage is associated with significantly higher mortality and major bleeding. [Display omitted] •In unselected patients with AMI complicated by CS, use of Impella is burdened by higher mortality compared to IABP.•Higher mortality with Impella is likely attributable to increased rate of major bleeding and renal complications.•Since not all patients benefit from Impella, its usage should be tailored to the patient clinical presentation.</description><subject>Acute myocardial infarction</subject><subject>Adverse events</subject><subject>Cardiogenic shock</subject><subject>Impella</subject><subject>Intra-aortic balloon pump</subject><subject>Major bleeding</subject><subject>Mortality</subject><subject>Percutaneous mechanical circulatory support</subject><issn>0167-5273</issn><issn>1874-1754</issn><issn>1874-1754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kMuO1DAQRS0EYpqBP0DISzZp_Epss0DKtHhEmhZIA2vLsSuDmyRu7ATUf0-iDCxZ1aLOrcdB6CUle0po9ea0Dydnk98zwsSeciYofYR2VElRUFmKx2i3YLIomeRX6FnOJ0KI0Fo9RVdcEy0qXu7Q72PD6mNTHO7e4hoPMNnCjra_5JCxi8PZpjDe42Y4Q99bbEePm_rmC47ztHQh4zDi2s0T4OMlrtcE2-Nm7GxyU4hjkaC3E3h8WFvxHsbg8N336H48R08622d48VCv0bcP778ePhW3nz82h_q2cEzJqQDCpXJtW9mWaCY6ahkoqa0G7n1bMii7UnrV8tZxyUgnfaVcR5TmtuJCC36NXm9zzyn-nCFPZgjZrc-MEOdsOFGyrFglyIKKDXUp5pygM-cUBpsuhhKzKjcnsyk3q3KzKV9irx42zO0A_l_or-MFeLcBsPz5K0Ay2QUYHfiQwE3Gx_D_DX8AK-iTXQ</recordid><startdate>20241101</startdate><enddate>20241101</enddate><creator>De Ferrari, Tommaso</creator><creator>Pistelli, Lorenzo</creator><creator>Franzino, Marco</creator><creator>Molinero, Agustin Ezequiel</creator><creator>De Santis, Giulia Azzurra</creator><creator>Di Carlo, Alessandro</creator><creator>Vetta, Giampaolo</creator><creator>Parlavecchio, Antonio</creator><creator>Fimiani, Luigi</creator><creator>Picci, Andrea</creator><creator>Certo, Giuseppe</creator><creator>Parisi, Francesca</creator><creator>Venuti, Giuseppe</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20241101</creationdate><title>MI2AMI-CS: A meta-analysis comparing Impella and IABP outcomes in Acute Myocardial Infarction-related Cardiogenic Shock</title><author>De Ferrari, Tommaso ; Pistelli, Lorenzo ; Franzino, Marco ; Molinero, Agustin Ezequiel ; De Santis, Giulia Azzurra ; Di Carlo, Alessandro ; Vetta, Giampaolo ; Parlavecchio, Antonio ; Fimiani, Luigi ; Picci, Andrea ; Certo, Giuseppe ; Parisi, Francesca ; Venuti, Giuseppe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c287t-e0378cbb6ab0924f1a2e879a9e3ddb52e5f57d8b3bc3720f7d68cf0893a634943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acute myocardial infarction</topic><topic>Adverse events</topic><topic>Cardiogenic shock</topic><topic>Impella</topic><topic>Intra-aortic balloon pump</topic><topic>Major bleeding</topic><topic>Mortality</topic><topic>Percutaneous mechanical circulatory support</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>De Ferrari, Tommaso</creatorcontrib><creatorcontrib>Pistelli, Lorenzo</creatorcontrib><creatorcontrib>Franzino, Marco</creatorcontrib><creatorcontrib>Molinero, Agustin Ezequiel</creatorcontrib><creatorcontrib>De Santis, Giulia Azzurra</creatorcontrib><creatorcontrib>Di Carlo, Alessandro</creatorcontrib><creatorcontrib>Vetta, Giampaolo</creatorcontrib><creatorcontrib>Parlavecchio, Antonio</creatorcontrib><creatorcontrib>Fimiani, Luigi</creatorcontrib><creatorcontrib>Picci, Andrea</creatorcontrib><creatorcontrib>Certo, Giuseppe</creatorcontrib><creatorcontrib>Parisi, Francesca</creatorcontrib><creatorcontrib>Venuti, Giuseppe</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>De Ferrari, Tommaso</au><au>Pistelli, Lorenzo</au><au>Franzino, Marco</au><au>Molinero, Agustin Ezequiel</au><au>De Santis, Giulia Azzurra</au><au>Di Carlo, Alessandro</au><au>Vetta, Giampaolo</au><au>Parlavecchio, Antonio</au><au>Fimiani, Luigi</au><au>Picci, Andrea</au><au>Certo, Giuseppe</au><au>Parisi, Francesca</au><au>Venuti, Giuseppe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MI2AMI-CS: A meta-analysis comparing Impella and IABP outcomes in Acute Myocardial Infarction-related Cardiogenic Shock</atitle><jtitle>International journal of cardiology</jtitle><addtitle>Int J Cardiol</addtitle><date>2024-11-01</date><risdate>2024</risdate><volume>414</volume><spage>132411</spage><pages>132411-</pages><artnum>132411</artnum><issn>0167-5273</issn><issn>1874-1754</issn><eissn>1874-1754</eissn><abstract>Cardiogenic Shock (CS) complicating acute myocardial infarction (AMI) poses a significant mortality risk, suggesting the opportunity to implement effective mechanical circulatory support strategies. The comparative efficacy of Intra-Aortic Balloon Pump (IABP) and Impella in managing CS-AMI remains a subject of investigation. This meta-analysis aims to evaluate the comparative effectiveness of Impella and IABP in managing CS-AMI, exploring mortality and adverse events. A systematic search of major databases from inception to November 2023 identified eight studies, comprising 10,628 patients, comparing Impella and IABP in CS-AMI. Retrospective studies (preferably Propensity-matched) and Randomized Clinical Trials (RCTs) were included. Impella use exhibited significantly higher mortality (57% vs. 46%; OR: 1.44, 95% CI: 1.29–1.60; p &lt; 0.001) and major bleeding (30% vs 15%; OR: 2.93, 95% CI: 1.67–5.13; p &lt; 0.001). In unselected CS-AMI patients, Impella usage is associated with significantly higher mortality and major bleeding. [Display omitted] •In unselected patients with AMI complicated by CS, use of Impella is burdened by higher mortality compared to IABP.•Higher mortality with Impella is likely attributable to increased rate of major bleeding and renal complications.•Since not all patients benefit from Impella, its usage should be tailored to the patient clinical presentation.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>39094635</pmid><doi>10.1016/j.ijcard.2024.132411</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0167-5273
ispartof International journal of cardiology, 2024-11, Vol.414, p.132411, Article 132411
issn 0167-5273
1874-1754
1874-1754
language eng
recordid cdi_proquest_miscellaneous_3087562640
source Access via ScienceDirect (Elsevier)
subjects Acute myocardial infarction
Adverse events
Cardiogenic shock
Impella
Intra-aortic balloon pump
Major bleeding
Mortality
Percutaneous mechanical circulatory support
title MI2AMI-CS: A meta-analysis comparing Impella and IABP outcomes in Acute Myocardial Infarction-related Cardiogenic Shock
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T10%3A44%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MI2AMI-CS:%20A%20meta-analysis%20comparing%20Impella%20and%20IABP%20outcomes%20in%20Acute%20Myocardial%20Infarction-related%20Cardiogenic%20Shock&rft.jtitle=International%20journal%20of%20cardiology&rft.au=De%20Ferrari,%20Tommaso&rft.date=2024-11-01&rft.volume=414&rft.spage=132411&rft.pages=132411-&rft.artnum=132411&rft.issn=0167-5273&rft.eissn=1874-1754&rft_id=info:doi/10.1016/j.ijcard.2024.132411&rft_dat=%3Cproquest_cross%3E3087562640%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3087562640&rft_id=info:pmid/39094635&rft_els_id=S0167527324010337&rfr_iscdi=true